Electrocardiogram abnormalities induced by amsacrine
- 1 February 1983
- journal article
- case report
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 10 (2) , 133-134
- https://doi.org/10.1007/bf00446226
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ventricular Fibrillation, Hypokalemia, and AMSA TherapyAnnals of Internal Medicine, 1982
- CARDIAC ABNORMALITIES AFTER AMSA ADMINISTRATION1982
- Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).1980
- Multiple ventricular extrasystoles following administration of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA).1980
- m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program.1980
- Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.1979
- Quinidine-induced ventricular flutter and fibrillation without digitalis therapyThe American Journal of Cardiology, 1976
- Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B.American Heart Journal, 1975
- Q-T interval syndromesProgress in Cardiovascular Diseases, 1974